Eli Lilly Adds Warning to Sepsis Drug Xigris (Reuters)


Reuters - Eli Lilly and Co. added a warning to
its sepsis drug Xigris after two trials linked it to a higher
death rate in patients who have single organ dysfunction and
have recently had surgery, a company letter made public on
Thursday said.

Read more...